PROFIT - Prostate Fractionated Irradiation Trial
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Charles Catton, MD
Princess Margaret Hospital, Canada
Principal Investigator - Himu Lukka, MD
Juravinski Cancer Centre
Principal Investigator - Jim Julian, MMATH
McMaster University - Department of Oncology
Principal Investigator - Mark Levine, MD
Ontario Clinical Oncology Group (OCOG)
Study Director
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
25 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Liverpool Hospital & Campbelltown Hospital
Liverpool, New South Wales, Australia
- Calvary Mater Newcastle Hospital
Newcastle, New South Wales, Australia
- Northern Sydney Cancer Centre, Royal North Shore Hospital
St Leonards, New South Wales, Australia
- Westmead Cancer Care Centre
Wentworthville, New South Wales, Australia
- Wollongong Hospital / Illawarra Cancer Care Centre
Wollongong, New South Wales, Australia
- Toowoomba Cancer Research Centre
Toowoomba, Queensland, Australia
- Princess Alexandra Hospital
Woolloongabba, Queensland, Australia
- Ballarat Austin Radiation Oncology Centre (baroc)
Ballarat, Victoria, Australia
- Peter Maccallum Cancer Centre
Melbourne, Victoria, Australia
- Tom Baker Cancer Centre
Calgary, Alberta, Canada
- Cross Cancer Institute
Edmonton, Alberta, Canada
- Cancercare Manitoba
Winnipeg, Manitoba, Canada
- Dr. H. Bliss Murphy Cancer Centre
St. John's, Newfoundland and Labrador, Canada
- Juravinski Cancer Centre
Hamilton, Ontario, Canada
- London Regional Cancer Centre
London, Ontario, Canada
- the Credit Valley Hospital - Carlo Fidani Peel Regional Cancer Centre
Mississauga, Ontario, Canada
- Stronach Regional Cancer Centre, Southlake Regional Health Centre
Newmarket, Ontario, Canada
- R.S. Mclaughlin Durham Regional Cancer Centre
Oshawa, Ontario, Canada
- Odette Sunnybrook Cancer Centre
Toronto, Ontario, Canada
- Princess Margaret Hospital
Toronto, Ontario, Canada
- Windsor Regional Cancer Centre
Windsor, Ontario, Canada
- Chum - Hôpital Notre-Dame
Montreal, Quebec, Canada
- Montréal General Hospital
Montreal, Quebec, Canada
- Allan Blair Cancer Centre
Regina, Saskatchewan, Canada
- Centre René Gauducheau
Nantes, Saint Herblain, France
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 31 May 2006
- Primary completion
- 15 Jul 2017
- Completion
- 15 Jul 2017
- Last update posted
- 31 Jul 2017
- Registered enrollment
- 1,204
- Registry id
- NCT00304759
Cross-registrations
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.